Compare · BE vs TMO
BE vs TMO
Side-by-side comparison of Bloom Energy Corporation (BE) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- BE operates in Energy, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $172.66B, about 1.8x BE ($93.56B).
- Over the past year, BE is up 1358.7% and TMO is up 16.2% - BE leads by 1342.5 points.
- BE has been more active in the news (13 items in the past 4 weeks vs 3 for TMO).
- Both have 25 recent analyst ratings on file.
- Company
- Bloom Energy Corporation
- Thermo Fisher Scientific Inc
- Price
- $328.78+15.31%
- $464.76+0.67%
- Market cap
- $93.56B
- $172.66B
- 1M return
- +25.63%
- +3.73%
- 1Y return
- +1358.65%
- +16.17%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2018
- News (4w)
- 13
- 3
- Recent ratings
- 25
- 25
Bloom Energy Corporation
Bloom Energy Corporation designs, manufactures, and sells solid-oxide fuel cell systems for on-site power generation in the United States, Japan, China, India, and the Republic of Korea. The company offers Bloom Energy Server, a power generation platform that converts standard low-pressure natural gas, biogas, or hydrogen into electricity through an electrochemical process without combustion. It serves hospitals, healthcare companies, retailers, and data centers. The company was formerly known as Ion America Corp. and changed its name to Bloom Energy Corporation in September 2006. Bloom Energy Corporation was incorporated in 2001 and is headquartered in San Jose, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest BE
- A Nasdaq Company Just Reinvented Itself as a Power Company — and Bet It All on the AI Energy Crunch
- The AI Boom's Real Bottleneck Is Power — and One Nasdaq Company Is Reinventing Itself to Solve It
- Chief Commercial Officer Joshi Aman sold $1,028,760 worth of shares (3,558 units at $289.14) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 172,150 units (SEC Form 4) (withholding tax)
- Chief Accounting Officer Kurzymski Maciej sold $651,993 worth of shares (2,259 units at $288.62), decreasing direct ownership by 3% to 79,686 units (SEC Form 4) (tax withholding)
- Chief Operations Officer Chitoori Satish sold $820,205 worth of shares (2,837 units at $289.11) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 207,417 units (SEC Form 4) (tax liability)
- Officer Soderberg Shawn Marie sold $820,286 worth of shares (2,842 units at $288.63), decreasing direct ownership by 2% to 132,265 units (SEC Form 4) (tax withholding)
- SEC Form 8-K filed by Bloom Energy Corporation
- Bernstein initiated coverage on Bloom Energy with a new price target
- SEC Form 144 filed by Bloom Energy Corporation
- AI Data Center Growth Hinges on Solving Both Power Constraints and Community Concerns, Bloom Energy Report Finds
Latest TMO
- Piper Sandler initiated coverage on Thermo Fisher with a new price target
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)